TipRanks
Kohjin Bio Co.,Ltd. (JP:177A)
:177A
Japanese Market
Want to see JP:177A full AI Analyst Report?

Kohjin Bio Co.,Ltd. (177A) Price & Analysis

0 Followers

177A Stock Chart & Stats

¥1525.00
-¥17.00(-1.03%)
At close: 4:00 PM EST
¥1525.00
-¥17.00(-1.03%)

Bulls Say, Bears Say

Bulls Say
Improving LeverageDeclining debt-to-equity indicates a stronger and more manageable capital structure than in prior years. This gives the company greater financial resilience and flexibility to sustain operations or pursue investment while reducing the balance-sheet burden if earnings remain under pressure.
Stronger Equity BaseA larger equity base improves the company’s ability to absorb earnings volatility and supports balance-sheet stability. This provides a durable foundation for funding the business and reduces reliance on leverage, even though recent profitability has weakened.
Positive Operating Cash FlowPositive operating cash flow shows that the underlying business continues to generate cash from its activities, providing some support for ongoing operations. Although investment outflows produced negative free cash flow, operating cash generation remains a fundamental source of resilience.
Bears Say
Declining RevenueThe shift from slightly positive to negative revenue growth signals weakening top-line momentum and raises questions about demand and business expansion. If this persists, slower revenue progression could constrain operating leverage, investment capacity, and the company’s ability to rebuild profitability.
Sharp Margin CompressionThe substantial decline in both net and operating margins shows that earnings quality has deteriorated materially, not merely that growth slowed. Sustained compression would reduce internal funding capacity and make future earnings more sensitive to changes in revenue and costs.
Negative Free Cash FlowNegative free cash flow weakens cash conversion and means reported earnings are not currently translating into funds available after investment. The pack also describes volatility versus earnings, creating a durable concern for self-funded growth and financial flexibility over coming periods.

177A FAQ

What was Kohjin Bio Co.,Ltd.’s price range in the past 12 months?
Kohjin Bio Co.,Ltd. lowest stock price was ¥750.00 and its highest was ¥1882.00 in the past 12 months.
    What is Kohjin Bio Co.,Ltd.’s market cap?
    Kohjin Bio Co.,Ltd.’s market cap is ¥3.87B.
      When is Kohjin Bio Co.,Ltd.’s upcoming earnings report date?
      Kohjin Bio Co.,Ltd.’s upcoming earnings report date is Nov 13, 2026 which is in 13 days.
        How were Kohjin Bio Co.,Ltd.’s earnings last quarter?
        Kohjin Bio Co.,Ltd. released its earnings results on Aug 14, 2026. The company reported -¥8.2 earnings per share for the quarter.
          Is Kohjin Bio Co.,Ltd. overvalued?
          According to Wall Street analysts Kohjin Bio Co.,Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Kohjin Bio Co.,Ltd. pay dividends?
            Kohjin Bio Co.,Ltd. pays a Annually dividend of ¥10 which represents an annual dividend yield of 1.32%. See more information on Kohjin Bio Co.,Ltd. dividends here
              What is Kohjin Bio Co.,Ltd.’s EPS estimate?
              Kohjin Bio Co.,Ltd.’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Kohjin Bio Co.,Ltd. have?
              Kohjin Bio Co.,Ltd. has 5,111,600 shares outstanding.
                What happened to Kohjin Bio Co.,Ltd.’s price movement after its last earnings report?
                Kohjin Bio Co.,Ltd. reported an EPS of -¥8.2 in its last earnings report. Following the earnings report the stock price went down -1.464%.
                  Which hedge fund is a major shareholder of Kohjin Bio Co.,Ltd.?
                  Currently, no hedge funds are holding shares in JP:177A
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    Company Description

                    Kohjin Bio Co.,Ltd.

                    Kohjin Bio Co., Ltd., established in 1981 in Sakado, Japan, and known as Kohjin Co.,Ltd. until its rebranding in 1989, is a diversified life science enterprise. The company's core business involves the production and sale of various biological materials, including animal blood, sera, cell culture media, agar media for microbial assays, in-vitro diagnostic products, and cosmetics. Its extensive catalog for cell and tissue culture features specialized mediums crucial for virus and recombinant protein synthesis, hybridoma development, human lymphocyte cultivation, and insect cell lines. Additionally, Kohjin Bio supplies complementary items such as gas-permeable cell culture bags, cryopreservation agents, medium supplements, normal human cells along with their growth media, ES cell media, and comprehensive kits for in-vitro fertilization and early embryo culture. The firm further provides essential laboratory tools like cell separation solutions, physiological salt solutions, and a range of research reagents. Within microbiology, Kohjin Bio offers a wide array of culture media tailored for various applications. For clinical diagnostics, this includes mediums for identifying gram-positive cocci and gram-negative bacteria, susceptibility testing, general differentiation, anaerobic growth, and fungal detection, alongside tube mediums for confirmatory tests and expansion. For food safety, their products cover sterilization assessments, and the detection of E. coli, coliform bacteria, Staphylococcus spp., Bacillus cereus, and Vibrio parahaemolyticus. The company also produces mediums for total viable cell count determination and specific media for Campylobacter and fungi. The company's blood and serum division offers normal human blood, serum, and plasma, as well as pathological human serum. Its animal blood portfolio encompasses preserved, defibrinated, and hemolyzed animal blood, in addition to animal serum and plasma, with custom-designed formulations like Eagle medium also available. Beyond its manufacturing activities, Kohjin Bio engages in the breeding and distribution of laboratory animals, the sale of medical equipment, and provides contract services for animal immunization and antibody preparation. The company also manages the import and export of its diverse products and raw materials internationally.

                    Kohjin Bio Co.,Ltd. (177A) Earnings & Revenues

                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    StemRIM Inc.
                    ―
                    ―
                    ―
                    ―
                    ―
                    ReproCELL Inc.
                    ―
                    ―
                    Japan Tissue Engineering Co., Ltd.
                    ―
                    ―
                    CellSeed Inc.
                    ―
                    ―
                    Popular Stocks